| Literature DB >> 35447698 |
Maria Teresa Viviano1, Alessia Provini2, Cinzia Mazzanti1, Steven Paul Nisticò3, Cataldo Patruno3, Giovanni Cannarozzo3, Stefano Bennardo3, Irene Fusco4, Luigi Bennardo3.
Abstract
A large part of the world's population suffers from Striae distensae (SD) or stretch marks, which create physical and psychological discomfort in people. We evaluate the SD clinical improvement by using a non-ablative fractional Nd:YAP 1340 nm laser. The research was performed on 25 patients of both sexes, with a mean age of 31 ± 13.09 years. Each patient underwent from a minimum of 3 to a maximum of 4 treatments, with an Nd:YAP (1340 nm) medical device, every four weeks, with 3- and 6-month follow-up, in these areas: back, abdomen, breast, flanks, lower limbs, buttocks, and thighs. Manchester Scar Scale assessed stretch marks improvement. Side effects, patient pain, and SD overall appearance improvement were also recorded for all patients. Digital photographs measured the aesthetic results. Treatment was well-tolerated (pain score 1.08 ± 0.76) by all patients. There were no long-term side effects, and 88% of patients revealed an SD excellent improvement showing good aesthetic results achieved by the treatment. The total mean pretreatment Manchester Scar Scale score decreased from 13.80 (±1.58) to 10.36 (±1.70) after 3 months (p < 0.01) and to 8.36 (±1.07) after 6 months (p < 0.01). An Nd:YAP (1340 nm) laser seems to be a safe and effective treatment, showing a higher security profile with no side effects.Entities:
Keywords: non-ablative fractional laser; stretch marks; striae
Year: 2022 PMID: 35447698 PMCID: PMC9027695 DOI: 10.3390/bioengineering9040139
Source DB: PubMed Journal: Bioengineering (Basel) ISSN: 2306-5354
Parameters of Manchester Scar Scale and mean scores related to each parameter at 3M FU and 6M FU.
| Parameters of Manchester Scar Scale | Baseline Mean ± SD | 3M FU Mean ±SD | Percentage Change between Pre-Treatment and 3M FU | 6M FU Mean ± SD | Percentage Change between Pre-Treatment and 6M FU |
|---|---|---|---|---|---|
| Color | 3.56 ± 0.50 | 2.60 ± 0.50 | 26.96% | 2.08 ± 0.28 | 41.57% |
| Finish | 2.00 ± 0.00 | 1.12 ± 0.33 | 44.00% | 1.00 ± 0.00 | 50.00% |
| Contour | 2.28 ± 0.54 | 1.96 ± 0.53 | 14.03% | 1.36 ± 0.49 | 40.35% |
| Distortion | 3.36 ± 0.49 | 2.48 ± 0.58 | 26.19% | 2.12 ± 0.44 | 36.90% |
| Texture | 2.6 ± 0.64 | 2.20 ± 0.50 | 15.38% | 1.80 ± 0.41 | 30.80% |
Figure 1Histogram representation of the mean parameters scores of Manchester Scar Scale.
Total Manchester Scar Scale scores.
| Manchester Scar Scale | Mean ± SD | Percentage Change between Pre-Treatment and Follow Up (Significance) |
|---|---|---|
| Pre-treatment Score | 13.80 ± 1.58 | |
| 3 Months Follow Up Score | 10.36 ± 1.70 | 24.92% ( |
| 6 Months Follow Up Score | 8.36 ± 1.07 | 39.42% ( |
Figure 2Histogram representation of the mean total score of Manchester Scar Scale.
Figure 3Photographic image of a male patient’s back area with Striae distensae (SD) before treatment (A), immediately after treatment (B), and 6M FU (C) after the last treatment with Nd:YAP 1340 nm laser. A visible and excellent aesthetic improvement of SD is shown.
Figure 4Photographic image of a patient’s umbilicus area with Striae distensae (SD) before treatment (A) and at 3M FU after the last treatment with Nd:YAP 1340 nm laser (B). A visible aesthetic improvement of SD is shown.